Karen Lu, MD

Associations

• Gynecologic Oncology
• Health Outcomes & Behavior Program

• Gootzen TA, Steenbeek MP, van Gelder MMHJ, van Bommel MHD, Timmer-Bonte JNH, Kets CM, Wilke RN, Swisher EM, Norquist BM, Lu KH, Hermens RPMG, de Hullu JA. Impact of breast cancer history on decision-making for ovarian cancer risk-reducing surgery in the TUBA-WISP-II study. Am J Obstet Gynecol. 2025 Jun. Pubmedid: 40532962.
• Ring KL, Mills AM, Howitt BE, Grisham RN, Euscher ED, Kim HS, Klopp AH, Kolin DL, McCluggage WG, Mirkovic J, Park KJ, Aoun E, Awujo C, Son J, Mok SC, Ferri-Borgogno S, Hong DS, Hoang L, Jazaeri AA, How JA, Lu KH. Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics. Gynecol Oncol. 2025 Jun.197:57-65. Pubmedid: 40279981.
• Aoun E, Lawson B, Awujo C, Nebgen D, Soletsky BR, Chisholm GB, Lu KH, Nitecki Wilke R. Oncologic outcomes of incidental serous tubal intraepithelial carcinoma and associated high-grade serous carcinoma in high-risk patients undergoing risk-reducing surgery. Int J Gynecol Cancer. 2025 Jan. Pubmedid: 39496390.
• Faupel-Badger J, Kohaar I, Bahl M, Chan AT, Campbell JD, Ding L, De Marzo AM, Maitra A, Merrick DT, Hawk ET, Wistuba II, Ghobrial IM, Lippman SM, Lu KH, Lawler M, Kay NE, Tlsty TD, Rebbeck TR, Srivastava S. Defining precancer: a grand challenge for the cancer community. Nat Rev Cancer. 2024 Nov.24(11):792-809. Pubmedid: 39354069.
• Bednar EM, Nitecki Wilke R, Jorgensen K, Walsh MT, Nutt S, Lu KH, Nóbrega L, De Souza APSD, da Silva Oliveira G, da Cunha Andrade CEM, Purizaca-Rosillo N, Mora P, López Blanco A, Gallardo-Alvarado LN, Cantú-de León D, Rauh-Hain JA. Feasibility of an environmental scan-based approach to collecting information about factors impacting cancer genetics services in Latin American countries. J Community Genet. 2024 Dec.15(6):681-686. Pubmedid: 39397225. Pmcid: PMC11645378.